These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6140316)

  • 41. Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli.
    Källenius G; Svenson S; Möllby R; Cedergren B; Hultberg H; Winberg J
    Lancet; 1981 Sep; 2(8247):604-6. PubMed ID: 6116085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterisation of Escherichia coli strains associated with canine urinary tract infections.
    Westerlund B; Pere A; Korhonen TK; Jarvinen AK; Siitonen A; Williams PH
    Res Vet Sci; 1987 May; 42(3):404-6. PubMed ID: 2887017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of type-1 fimbriae in the pathogenesis of chronic pyelonephritis in relation to reactive oxygen species.
    Gupta R; Gupta S; Ganguly NK
    J Med Microbiol; 1997 May; 46(5):403-6. PubMed ID: 9152036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiological aspects of P-fimbriated Escherichia coli. IV. Extraintestinal E. coli infections before the age of one year and their relation to fecal colonization with P-fimbriated E. coli.
    Tullus K; Källenius G
    Acta Paediatr Scand; 1987 May; 76(3):463-9. PubMed ID: 2885999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects.
    Geerlings SE; Meiland R; van Lith EC; Brouwer EC; Gaastra W; Hoepelman AI
    Diabetes Care; 2002 Aug; 25(8):1405-9. PubMed ID: 12145242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid identification of P-fimbriated Escherichia coli by a receptor-specific particle agglutination test.
    Svenson SB; Källenius G; Möllby R; Hultberg H; Winberg J
    Infection; 1982; 10(4):209-14. PubMed ID: 6127318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluorescence-activated cell analysis of P-fimbriae receptor accessibility on uroepithelial cells of patients with renal scarring.
    Jacobson S; Carstensen A; Källenius G; Svenson S
    Eur J Clin Microbiol; 1986 Dec; 5(6):649-54. PubMed ID: 3542529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney.
    Rice JC; Peng T; Spence JS; Wang HQ; Goldblum RM; Corthésy B; Nowicki BJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3583-91. PubMed ID: 16236807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of Dr adhesin with collagen type IV is a critical step in Escherichia coli renal persistence.
    Selvarangan R; Goluszko P; Singhal J; Carnoy C; Moseley S; Hudson B; Nowicki S; Nowicki B
    Infect Immun; 2004 Aug; 72(8):4827-35. PubMed ID: 15271945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
    Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa.
    Godaly G; Otto G; Burdick MD; Strieter RM; Svanborg C
    Kidney Int; 2007 Apr; 71(8):778-86. PubMed ID: 17228365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the variability of S-fimbriae expression in an Escherichia coli pathogen.
    Ott M; Hacker J
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):233-8. PubMed ID: 1676382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adhesiveness to urinary tract epithelial cells of fecal and urinary Escherichia coli isolates from patients with symptomatic urinary tract infections or asymptomatic bacteriuria of varying duration.
    Edén CS; Janson GL; Lindberg U
    J Urol; 1979 Aug; 122(2):185-8. PubMed ID: 379371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virulence characteristics of Escherichia coli in relation to host response in men with symptomatic urinary tract infection.
    Ulleryd P; Lincoln K; Scheutz F; Sandberg T
    Clin Infect Dis; 1994 Apr; 18(4):579-84. PubMed ID: 7913633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Host-parasite relationships in acute pyelonephritis.
    Roberts JA; Suarez GM; Kaack B; Domingue GJ; Svenson SB
    Am J Kidney Dis; 1986 Sep; 8(3):139-45. PubMed ID: 3529942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [P-fimbriae receptor interaction. New discoveries in pyelonephritis and urinary sepsis].
    Källenius G; Möllby R; Svenson SB; Tullus K
    Lakartidningen; 1985 Apr; 82(15):1349-52. PubMed ID: 2859408
    [No Abstract]   [Full Text] [Related]  

  • 57. Fecal colonization with P-fimbriated Escherichia coli as a predictor of acute pyelonephritis in infancy--a prospective study.
    Tullus K
    Infection; 1988; 16(5):267-8. PubMed ID: 2905694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
    Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME
    FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of pyelonephritis by immunization with P-fimbriae.
    Roberts JA; Hardaway K; Kaack B; Fussell EN; Baskin G
    J Urol; 1984 Mar; 131(3):602-7. PubMed ID: 6199527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Relation between P-fimbriae and resistance to amoxicillin, carbenicillin and tetracycline in uropathogenic strains of Escherichia coli].
    Vranes J; Schönwald S; Zagar Z
    Lijec Vjesn; 1994; 116(7-8):178-81. PubMed ID: 7853994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.